Actinomycin D for fibrosis management in ophthalmic implant surgery
Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
De Gruyter
2019-09-01
|
| Seri Bilgileri: | Current Directions in Biomedical Engineering |
| Konular: | |
| Online Erişim: | https://doi.org/10.1515/cdbme-2019-0121 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|